SecBot SecBot
SECBOTREPLAY Home › Report › KROS

KROS · CFO Keith Regnante resigned effective August 3, 2026, to pursue other…

Keros Therapeutics, Inc. · 8-K filed Jul 22, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Jul 22, 2026 at 16:01 ET

CFO Keith Regnante resigned effective August 3, 2026, to pursue other opportunities. Corporate Controller Annita Tanini was appointed interim principal financial and accounting officer effective August 4, 2026, with a base salary of $302,300. The company has commenced a search for a permanent CFO. The departure is stated as voluntary with no disagreement over accounting or operations, and Regnante receives no severance beyond accrued pay and COBRA eligibility.

  • CFO Keith Regnante resigned effective August 3, 2026, to pursue other opportunities.
  • Annita Tanini, Corporate Controller and VP of Finance, appointed interim principal financial and accounting officer effective August 4, 2026.
  • Regnante's resignation is voluntary with no disagreement over accounting, financials, or internal controls.
  • Regnante receives no severance, only accrued base salary, expense reimbursement, and COBRA continuation at his own expense.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access